Dyslipidemia News and Research

RSS

Dyslipidemia is a disruption in the amount of lipids in the blood.

Edible activated charcoal may prevent weight gain

ith the westernization of eating habits, the proportion of obese people is increasing all over the world. Obesity is an urgent issue because obesity is a risk factor leading to various diseases such as diabetes, fatty liver and dyslipidemia.

15 Jul 2022

Black individuals may be more vulnerable to atherosclerosis early in life than young Hispanic adults

A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.

11 Jul 2022

Smoking cigarettes while wearing a mask may impair blood vessel function

Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods.

8 Jul 2022

Ischemic stroke patients with no previously diagnosed risk factors found to have underlying conditions in most cases

People who suffer from ischemic strokes with no previously diagnosed risk factors have been found to have underlying conditions in the majority of cases, a new study presented today at the European Academy of Neurology (EAN) Congress 2022 has shown.

26 Jun 2022

Is the ability to complete a 10- second one-legged stance associated with all-cause mortality?

Researchers investigated the association between a complete 10-second one-legged stance and all-cause mortality.

23 Jun 2022

Pregnant women with PCOS have higher risk for heart problems during delivery

A common hormone disorder among women of reproductive age has been linked to an increased risk of adverse cardiovascular events and pregnancy outcomes at the time of birth, according to a new study led by Johns Hopkins Medicine researchers.

16 Jun 2022

Anti-SARS-CoV-2 titers predict COVID severity

A recent study published in the journal Viruses reported that antibody titers against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could serve as a marker for the severity of coronavirus disease 2019 (COVID-19).

22 May 2022

Serologic response to SARS-CoV-2 may predict COVID-19 severity

A new study reported that antibody titers against SARS-CoV-2 could serve as a marker for the severity of COVID-19.

20 May 2022

Lean people with NAFLD more likely to have cardiovascular disease than those who are overweight

Those with a normal body mass index (BMI) with non-alcoholic fatty liver disease (NAFLD) are more likely to have cardiovascular disease than those who are overweight or living with obesity, according to research selected for presentation at Digestive Disease Week 2022.

13 May 2022

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Researchers assessed the efficacy and safety of using lithium for coronavirus disease 2019 (COVID-19) treatment.

5 May 2022

Study investigates intestinal ischemia in COVID-19 patients

A team of Italian scientists has presented case reports of five coronavirus disease 2019 (COVID-19) patients undergoing emergency surgery for intestinal ischemia.

28 Apr 2022

Researchers calculate the impact of consuming ultra-processed foods on obesity risk

Based on data for 3,587 adolescents aged 12-19 who took part in the 2011-16 National Health and Nutrition Examination Survey (NHANES) in the United States, researchers at the University of São Paulo (USP) in Brazil have calculated the impact of consuming ultra-processed foods on the risk of obesity.

12 Apr 2022

Researchers investigate loss of fitness following COVID-19

Researchers investigate if a decline in exercise capabilities is due to deconditioning during infection or long-term reductions in ability due to COVID-19.

15 Mar 2022

Clinical decision support system may help improve cardiovascular health in patients with severe mental illness

In a new study, researchers demonstrated that they can significantly lower cardiovascular risk for patients with severe mental illness (SMI) by using a clinical decision support system that prompts doctors to provide individualized informational handouts about a patient's cardiovascular risk and treatment recommendations.

7 Mar 2022

Researchers highlight the extent to which NAFLD and diabetes jointly occur worldwide

Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, similar to the non-communicable diseases cancer, obesity, cardiovascular disease and diabetes.

18 Feb 2022

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

In a new study, researchers have been investigating the effects of megadoses of corticosteroids on hospitalized COVID-19 patients.

26 Jan 2022

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidemia from a young age, a new study published in Hypertension today suggests.

18 Jan 2022

Metabolic syndrome linked to worse hospitalization and mortality in COVID-19 patients

Patients with metabolic syndrome have significantly worse hospitalization and mortality rates due to COVID-19.

12 Jan 2022

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

Lifestyle habits play a key role in predicting the risk of metabolic syndrome in non-obese individuals

Researchers from Japan have found that lifestyle habits play an important role in predicting the risk of developing metabolic syndrome in non-obese individuals, not only obese individuals.

18 Nov 2021